Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
42.6M
-
Shares change
-
-11.8M
-
Total reported value, excl. options
-
$1.49B
-
Value change
-
-$414M
-
Put/Call ratio
-
1.34
-
Number of buys
-
80
-
Number of sells
-
-93
-
Price
-
$34.97
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q2 2025
197 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q2 2025.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.6M shares
of 1.09B outstanding shares and own 3.9% of the company stock.
Largest 10 shareholders include FMR LLC (6.2M shares), Capital World Investors (6.04M shares), RTW INVESTMENTS, LP (5.54M shares), Clearbridge Investments, LLC (4.01M shares), JANUS HENDERSON GROUP PLC (2.2M shares), BAMCO INC /NY/ (1.59M shares), WELLINGTON MANAGEMENT GROUP LLP (1.38M shares), Frazier Life Sciences Management, L.P. (1.31M shares), Woodline Partners LP (1.2M shares), and Allianz Asset Management GmbH (932K shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.